A
Ascertain
Develops healthcare AI companies that improve quality and access to care and close health equity gaps
About Ascertain
Ascertain.com is a pioneering startup operating in the healthcare and technology sectors, specifically focusing on the integration of artificial intelligence (AI) into healthcare systems. The company is a collaborative venture between Northwell Health and Aegis Ventures, aiming to disrupt healthcare inequities and improve patient care through AI solutions.
Ascertain's business model revolves around developing and launching AI-based healthcare companies on a large scale. The team, composed of clinicians, engineers, and business leaders, leverages their combined expertise in medicine, technology, data, and business to create a unique platform for this purpose. The company identifies and collaborates with top-notch operators to execute their mission, forming an interdisciplinary team of healthcare, technical, and business experts.
The startup serves health systems, aiming to help them better serve their communities and support those involved in the delivery of care. Ascertain's AI tools are designed to alleviate administrative burdens, allowing healthcare professionals to focus more on patient needs. This approach not only enhances the efficiency of healthcare delivery but also brings a more human-centered approach back into the healthcare industry.
Ascertain generates revenue by launching AI healthcare companies. These companies, built on Ascertain's platform, are designed to transform medicine and create a more equitable healthcare future. The startup's commitment to this goal is reflected in its continuous efforts to build companies that can achieve this transformation.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2022
- Headquarters
- New York City, United States
- Employees
- 59
- Open positions
- 15
- Dealroom signal
- 61.4/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Core AI, Hard Tech, AI Applications
- Technology
- Artificial Intelligence
- Business model
- SaaS
- Client focus
- b2b
- Investment activity
- 1 company
- Capital deployed
- —
- Preferred round
- Unknown
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Apr 2025 | $10M | $500M | Deerfield · Northwell Health | — |
| LATE VCOther financing | Apr 2022 | $100M | $400M | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Ascertain is 5.7K monthly website visits, down 35.2% over the last three months. Ascertain's team grew 63.9% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Deerfield
Northwell Health
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ascertain on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ascertain’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.